EP Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180M Buy
708,767
+97,152
+16% +$22.6M 0.69% 26
2026
Q1
$150M Sell
611,615
-15,817
-3% -$3.68M 0.74% 27
2025
Q4
$130M Buy
+627,432
New +$124M 0.67% 27
2025
Q2
$88.6M Buy
580,128
+17,552
+3% +$2.7M 0.58% 33
2025
Q1
$93.3M Buy
562,576
+18,238
+3% +$2.85M 0.75% 31
2024
Q4
$78.7M Sell
544,338
-381
-0.1% -$59K 0.64% 33
2024
Q3
$88.3M Buy
544,719
+44,526
+9% +$7.09M 0.76% 29
2024
Q2
$73.1M Buy
500,193
+29,039
+6% +$4.32M 0.78% 29
2024
Q1
$74.5M Buy
471,154
+12,135
+3% +$1.93M 0.87% 26
2023
Q4
$71.9M Buy
459,019
+6,188
+1% +$949K 0.92% 26
2023
Q3
$70.5M Buy
452,831
+446,960
+7,613% +$73.8M 1.09% 19
2023
Q2
$72.5M Sell
5,871
-108,874
-95% -$17.6M 1.05% 18
2023
Q1
$5.83M Sell
114,745
-278,399
-71% -$45M 0.1% 121
2022
Q4
$69.4M Buy
393,144
+3,234
+0.8% +$558K 1.25% 14
2022
Q3
$63.7M Buy
389,910
+37,491
+11% +$6.34M 1.44% 11
2022
Q2
$62.6M Buy
352,419
+9,578
+3% +$1.71M 1.41% 9
2022
Q1
$60.8M Buy
342,841
+11,232
+3% +$1.91M 1.33% 10
2021
Q4
$56.7M Buy
331,609
+13,896
+4% +$2.27M 1.34% 12
2021
Q3
$51.3M Buy
317,713
+4,573
+1% +$780K 1.41% 11
2021
Q2
$51.6M Buy
313,140
+12,592
+4% +$2.08M 1.43% 11
2021
Q1
$49.4M Buy
300,548
+18,271
+6% +$2.96M 1.57% 10
2020
Q4
$44.4M Buy
282,277
+19,654
+7% +$2.9M 1.56% 9
2020
Q3
$39.1M Buy
262,623
+12,009
+5% +$1.78M 1.68% 8
2020
Q2
$35.2M Buy
250,614
+4,573
+2% +$666K 1.51% 9
2020
Q1
$32.3M Buy
246,041
+23,457
+11% +$3.33M 1.58% 8
2019
Q4
$32.5M Buy
222,584
+5,342
+2% +$725K 1.34% 9
2019
Q3
$28.1M Buy
217,242
+4,293
+2% +$566K 1.39% 11
2019
Q2
$29.7M Buy
212,949
+44,327
+26% +$6.14M 1.85% 9
2019
Q1
$23.6M Buy
168,622
+3,947
+2% +$529K 2.27% 8
2018
Q4
$21.3M Buy
164,675
+5,714
+4% +$797K 1.64% 11
2018
Q3
$22M Buy
158,961
+14,460
+10% +$1.92M 1.72% 8
2018
Q2
$17.5M Buy
144,501
+4,964
+4% +$619K 1.65% 12
2018
Q1
$17.9M Buy
139,537
+11,512
+9% +$1.56M 1.73% 10
2017
Q4
$17.9M Buy
128,025
+3,201
+3% +$446K 1.89% 10
2017
Q3
$16.2M Buy
124,824
+5,618
+5% +$745K 1.87% 11
2017
Q2
$15.8M Buy
119,206
+3,435
+3% +$438K 1.93% 10
2017
Q1
$14.4M Buy
115,771
+5,756
+5% +$688K 1.99% 10
2016
Q4
$11.2M Buy
110,015
+4,430
+4% +$512K 1.64% 13
2016
Q3
$12.5M Sell
105,585
-761
-0.7% -$92.3K 1.95% 10
2016
Q2
$12.9M Sell
106,346
-14,179
-12% -$1.61M 2.06% 7
2016
Q1
$13M Sell
120,525
-14,573
-11% -$1.51M 2% 9
2015
Q4
$13.9M Buy
135,098
+4,260
+3% +$428K 2.33% 7
2015
Q3
$12.2M Sell
130,838
-257
-0.2% -$24.9K 2.33% 13
2015
Q2
$12.8M Buy
131,095
+4,553
+4% +$456K 2.39% 13
2015
Q1
$12.7M Buy
126,542
+4,950
+4% +$503K 2.39% 12
2014
Q4
$12.7M Buy
121,592
+1,185
+1% +$125K 2.1% 13
2014
Q3
$12.8M Buy
120,407
+3,177
+3% +$330K 2.08% 14
2014
Q2
$12.3M Buy
117,230
+5,884
+5% +$595K 2.85% 11
2014
Q1
$10.9M Buy
111,346
+5,411
+5% +$502K 2.99% 13
2013
Q4
$9.7M Buy
105,935
+2,412
+2% +$222K 2.52% 17
2013
Q3
$8.97M Sell
103,523
-1,328
-1% -$119K 2.82% 15
2013
Q2
$9M Buy
+104,851
New +$8.9M 3.25% 12

Other funds holding JNJ

EP Wealth Advisors's JNJ Position: Q2 2026 in Review

EP Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 16% in Q2 2026, buying an estimated $22.6M and bringing the position to 708,767 shares worth $180M. The position accounts for 0.69% of the portfolio, ranked #26.

EP Wealth Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • EP Wealth Advisors held 708,767 shares of Johnson & Johnson worth $180M as of Q2 2026.
  • EP Wealth Advisors bought 97,152 Johnson & Johnson shares in Q2 2026, an estimated $22.6M.
  • Johnson & Johnson made up 0.69% of EP Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • EP Wealth Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.